New Square Capital LLC Oncolytics Biotech Inc Transaction History

New Square Capital LLC

  • $1.23 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023
SELL
$1.11 - $2.74 $1,110 - $2,740
-1,000 Reduced 81.97%
220 $0
Q4 2022

Feb 06, 2023
BUY
$1.17 - $2.12 $1,427 - $2,586
1,220 New
1,220 $1,000

Others Institutions Holding ONCY

# of Institutions
44
Shares Held
1.18M
Call Options Held
0
Put Options Held
0
View Full List

About ONCOLYTICS BIOTECH INC

ONCY Quotes by TradingView
  • Ticker ONCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,867,400
  • Market Cap $49.2M
  • Description
  • Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...
More about ONCY
Track This Portfolio

Track New Square Capital LLC Portfolio

Follow New Square Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Square Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email